May 27, 2008 - Advanced Medical Isotope. (AMIC) has successfully produced Fluorine-18, a first in a series of isotopes that AMIC will begin manufacturing after receiving its radioactive materials license, awarded by the state of Washington on May 14, 2008.
“The award of the Radioactive Materials License is a very important milestone for our company," said AMIC CEO William J. Stokes. "It allows AMIC to proceed with startup operations of our showcase production center, which is built around the nation’s first compact proton linear accelerator used for isotope production.”
Immediately following the award of the license, AMIC began the hot functional testing of the linear accelerator, and produced its first batch of radioactive materials earlier this month.
“Now that we’ve accomplished this important milestone, our team is aggressively moving forward to complete the balance of systems testing and startup,” said James C. Katzaroff, AMIC’s president and chairman. “AMIC is on target for a mid-June delivery of our first AMIC-manufactured, pharmaceutical grade product for human use.”
For more information: www.isotopeworld.com
June 14, 2024 
